Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients.
Gringeri A, Santagostino E, Muça-Perja M, Mannucci PM, Zagury JF, Bizzini B, Lachgar A, Carcagno M, Rappaport J, Criscuolo M, Blattner W, Burny A, Gallo RC, Zagury D.
Gringeri A, et al. Among authors: lachgar a.
J Hum Virol. 1998 May-Jun;1(4):293-8.
J Hum Virol. 1998.
PMID: 10195254
Clinical Trial.